OMDA Omada Health, Inc. Insider Trading

Then-CFO Steven L. Cook sells 50,950 shares for $1.0M via pre-arranged 10b5-1 plan

Steven L. Cook, who was CFO at the time, executed 2 separate sales totaling 50,950 shares for $1,034,616.21 as part of a 10b5-1 trading plan adopted on 2026-03-14. The sales reduced his holdings by 30.6% (from 166,359 to 115,409 shares) at prices of $19.89 and $21.07 across two dates. Because this is a scheduled, pre-arranged transaction, it does not reflect discretionary timing or current conviction. The company posted revenue of $78,048,000.00 in its latest quarter with annual revenue growth of 53.2%, but remains unprofitable (most recent full fiscal year net income was negative). The stock has risen 22.2% over 30 days and 74.1% over 90 days, currently trading at $21.95, though it remains 18.5% below its 52-week high.

CEO Sean P. Duffy sold 271,275 shares for $4,245,925.86 across 3 transactions; stock down 42.1% from 52-week high.

Sean P. Duffy, Chief Executive Officer of Omada Health, executed 3 separate sales totaling 271,275 shares for $4,245,925.86, reducing his holdings by 68.2% from 397,919 shares to 126,644 shares. The sales occurred at prices ranging from $15.35 to $15.99, with a blended average of $15.65, while the stock currently trades at $15.50—near the lower end of the transaction prices and down 42.1% from its 52-week high of $26.78. The company reported net losses of $3,178,000 in the latest quarter against revenue of $68,030,000, suggesting operational headwinds. A CEO liquidating more than two-thirds of his position during a period of significant price depreciation and reported losses warrants investor attention to the underlying business trajectory.